BioLife BLFS Stock
BioLife Price Chart
BioLife BLFS Financial and Trading Overview
| BioLife stock price | 21.95 USD |
| Previous Close | 23.21 USD |
| Open | 23.01 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 900 |
| Day's Range | 22.59 - 23.36 USD |
| 52 Week Range | 13.35 - 26.96 USD |
| Volume | 190.52K USD |
| Avg. Volume | 290.78K USD |
| Market Cap | 992.37M USD |
| Beta (5Y Monthly) | 1.790845 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.25 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 30.71 USD |
BLFS Valuation Measures
| Enterprise Value | 996.95M USD |
| Trailing P/E | N/A |
| Forward P/E | -60.05263 |
| PEG Ratio (5 yr expected) | -2.73 |
| Price/Sales (ttm) | 6.0791407 |
| Price/Book (mrq) | 2.758704 |
| Enterprise Value/Revenue | 6.107 |
| Enterprise Value/EBITDA | -38.168 |
Trading Information
BioLife Stock Price History
| Beta (5Y Monthly) | 1.790845 |
| 52-Week Change | 65.48% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 26.96 USD |
| 52 Week Low | 13.35 USD |
| 50-Day Moving Average | 20.7 USD |
| 200-Day Moving Average | 21.63 USD |
BLFS Share Statistics
| Avg. Volume (3 month) | 290.78K USD |
| Avg. Daily Volume (10-Days) | 268.35K USD |
| Shares Outstanding | 43.49M |
| Float | 32.58M |
| Short Ratio | 8.44 |
| % Held by Insiders | 6.71% |
| % Held by Institutions | 91.61% |
| Shares Short | 2.65M |
| Short % of Float | 8.94% |
| Short % of Shares Outstanding | 6.09% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:14 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -89.49% |
| Operating Margin (ttm) | -25.27% |
| Gross Margin | 34.51% |
| EBITDA Margin | -16.0010% |
Management Effectiveness
| Return on Assets (ttm) | -5.20% |
| Return on Equity (ttm) | -34.92% |
Income Statement
| Revenue (ttm) | 163.24M USD |
| Revenue Per Share (ttm) | 3.82 USD |
| Quarterly Revenue Growth (yoy) | 4.10% |
| Gross Profit (ttm) | 54.07M USD |
| EBITDA | -26120000 USD |
| Net Income Avi to Common (ttm) | -146098000 USD |
| Diluted EPS (ttm) | -3.32 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 54.89M USD |
| Total Cash Per Share (mrq) | 1.26 USD |
| Total Debt (mrq) | 43.22M USD |
| Total Debt/Equity (mrq) | 12.07 USD |
| Current Ratio (mrq) | 2.806 |
| Book Value Per Share (mrq) | 8.272 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3276000 USD |
| Levered Free Cash Flow (ttm) | -7070250 USD |
Profile of BioLife
| Country | United States |
| State | WA |
| City | Bothell |
| Address | 3303 Monte Villa Parkway |
| ZIP | 98021 |
| Phone | (425) 402-1400 |
| Website | https://www.biolifesolutions.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 466 |
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; ultra-low temperature mechanical freezers; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
Q&A For BioLife Stock
What is a current BLFS stock price?
BioLife BLFS stock price today per share is 21.95 USD.
How to purchase BioLife stock?
You can buy BLFS shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioLife?
The stock symbol or ticker of BioLife is BLFS.
Which industry does the BioLife company belong to?
The BioLife industry is Medical Instruments & Supplies.
How many shares does BioLife have in circulation?
The max supply of BioLife shares is 47.55M.
What is BioLife Price to Earnings Ratio (PE Ratio)?
BioLife PE Ratio is now.
What was BioLife earnings per share over the trailing 12 months (TTM)?
BioLife EPS is -0.25 USD over the trailing 12 months.
Which sector does the BioLife company belong to?
The BioLife sector is Healthcare.
BioLife BLFS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17689.66 USD — |
-0.87
|
6.32B USD — | 17592.88 USD — | 17830.35 USD — | — - | 6.32B USD — |
| NASDAQ Composite Total Return I XCMP | 21656.65 USD — |
-0.87
|
— — | 21538.17 USD — | 21828.9 USD — | — - | — — |
| NASDAQ Capital Market Composite RCMP | 102.65 USD — |
-0.63
|
— — | 101.78 USD — | 103.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 906.89 USD — |
-4.12
|
— — | 905.36 USD — | 931.92 USD — | — - | — — |
- {{ link.label }} {{link}}